Get started
Author

Laiza Hombre Dias

Observed names: DIAS, L. H., L. H. Dias, L.H. Dias, LAIZA HOMBRE DIAS, Laiza Dias, Laiza H Dias, Laiza H. Dias
ORCID: 0000-0003-4101-0400
Observed ORCID: 0000-0003-4101-0400
OpenAlex ID: A5001106269
Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren’s syndrome: a randomized-controlled trial
2019 · Samira Tatiyama Miyamoto, Valéria Valim, et al. · Rheumatology International · 54
Pain and fatigue are predictors of quality of life in primary Sjögren’s syndrome
2021 · Laiza Hombre Dias, Samira Tatiyama Miyamoto, et al. · Revista Brasileira de Reumatologia · 53
PDF
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study
2020 · Valéria Valim, Ketty Lysie Libardi Lira Machado, et al. · Frontiers in Immunology · 32
PDF
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
2022 · Valéria Valim, Olindo Assis Martins-Filho, et al. · Frontiers in Immunology · 11
PDF
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register
2022 · Joana S Carvalho, Edgard T dos Reis Neto, et al. · Lupus · 8
PDF
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry
2022 · Ana Paula Monteiro Gomides, Cleandro Pires de Albuquerque, et al. · Revista Brasileira de Reumatologia · 8
PDF
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer
2024 · Vitor Alves Cruz, Camila Guimarães, et al. · Revista Brasileira de Reumatologia · 6
PDF
SAT0422 Impact of Symptoms and Disease Activity on Quality of Life in Primary SjÖgren's Syndrome
2015 · L.H. Dias, S.T. Miyamoto, et al. · Annals of the Rheumatic Diseases · 2
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis
2025 · Erika Biegelmeyer, Mariana de Freitas Aguiar, et al. · Frontiers in Immunology · 1
PDF
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study
2025 · Nésio Medeiros-Junior, Maria Gouvea, et al. · Vaccines · 1
PDF
Covid-19 Is Associated With Lupus Flare and Persistent Disease Activity: Longitudinal Data From the Reumacov-brazil Register
2025 · Joana De Carvalho, Edgard Torres, et al. · The Journal of Rheumatology · 1
AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY
2023 · V. Cruz, K. Lysie Libardi Lira Machado, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos0271 Heterologous Covid-19 Booster Vaccination Produced Greater Antibody Titers in Autoimmune Disease Patients: Data From Multicentric Prospective Phase Iv Safer Study
2023 · K. Lysie Libardi Lira Machado, S. T. Miyamoto, et al. · Annals of the Rheumatic Diseases · 1
PDF
COVID-19 is associated with lupus flare and persistent disease activity: longitudinal data from the ReumaCov-Brazil Register study
2026 · Joana S. Carvalho, Edgard T. dos Reis Neto, et al. · Revista Brasileira de Reumatologia
Ab0078 Predictors of Hospitalization Due to Breakthrough Covid-19 Infection in Patients With Immune-mediated Rheumatic Diseases: Data From Safer Study
2024 · D. Calderaro, K. Lysie Libardi Lira Machado, et al. · Annals of the Rheumatic Diseases
Ab0581 Bivalent Mrna Covid-19 Vaccine Booster Does Not Increase the Risk of Flare in Rheumatoid Arthritis Patients Under Real Life Setting – Data From Safer Study
2024 · V. Cruz, C. Guimarães, et al. · Annals of the Rheumatic Diseases
Covid-19 Was Associated With Lupus Disease Activity in Longitudinal Study: Reumacov- Brasil Register
2023 · Joana Starling de Carvalho, Edgard Torres dos Reis Neto, et al. · Congresso Brasileiro de Reumatologia
PDF
Mapping Covid-19 Impact on Immune-mediated Rheumatic Diseases in Brazil S Macroregions: Reumacov Brasil Data
2023 · Claudia Diniz Lopes Marques, Adriana Maria Kakehasi, et al. · Congresso Brasileiro de Reumatologia
PDF
The Impact of Covid-19 in Patients With Systemic Vasculitides. Data From Reumacov Brazil Register
2023 · João Pedro de Matos Assunção, Gustavo Gomes Resende, et al. · Congresso Brasileiro de Reumatologia
PDF
Safety assessment of BNT162b2, SinoVac and ChAdOx1 vaccines in Systemic Lupus Erythematosus patients in Brazil- SAFER Study
2022 · Flavia Maria Matos Melo Campos Peixoto, Juliana Bühring, et al. · Congresso Brasileiro de Reumatologia
PDF
Safety of COVID-19 vaccine in Connective Tissue Diseases and Systemic Vasculitis - A preliminary analysis from SAFER study
2022 · Erika Biegelmeyer, Mariana Freitas de Aguiar, et al. · Congresso Brasileiro de Reumatologia
PDF
Reatogenicity After Planned Vaccination With Chadox1, Sinovac and Bnt162b2 Vaccines in Patients With Autoimmune Disease: Data From the Safer Study
2022 · Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamato, et al. · Congresso Brasileiro de Reumatologia
PDF
Immunogenicity and Safety of the Chadox-1 Covid-19 Vaccine in Patients With Autoimmune Diseases and Healthy Controls: Data From Safer Study
2022 · Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, et al. · Congresso Brasileiro de Reumatologia
PDF
Yellow Fever Primary Vaccination Is Safe and Effective in Rheumatic Autoimmune Disease
2019 · VALERIA VALIM, ARTHUR DALMASO PINTO, et al.
PDF
Ab1298 Safety and Efficacy of Primary Yellow Fever Vaccination in Autoimmune Disease: a Prospective Controlled Study
2019 · Valeria Valim, Arthur Dalmaso Pinto, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 26
Citation count: 179
H-index: 6
I10-index: 4
Year
Topic
Type